Correlation Between Madrigal Pharmaceuticals and Nanologix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Nanologix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Nanologix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Nanologix, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Nanologix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Nanologix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Nanologix.

Diversification Opportunities for Madrigal Pharmaceuticals and Nanologix

0.17
  Correlation Coefficient

Average diversification

The 3 months correlation between Madrigal and Nanologix is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Nanologix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanologix and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Nanologix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanologix has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Nanologix go up and down completely randomly.

Pair Corralation between Madrigal Pharmaceuticals and Nanologix

Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to under-perform the Nanologix. But the stock apears to be less risky and, when comparing its historical volatility, Madrigal Pharmaceuticals is 46.2 times less risky than Nanologix. The stock trades about -0.01 of its potential returns per unit of risk. The Nanologix is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  0.00  in Nanologix on October 26, 2024 and sell it today you would earn a total of  0.01  from holding Nanologix or generate 9.223372036854776E16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Madrigal Pharmaceuticals  vs.  Nanologix

 Performance 
       Timeline  
Madrigal Pharmaceuticals 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Madrigal Pharmaceuticals are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain technical and fundamental indicators, Madrigal Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.
Nanologix 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Nanologix are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting essential indicators, Nanologix showed solid returns over the last few months and may actually be approaching a breakup point.

Madrigal Pharmaceuticals and Nanologix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Madrigal Pharmaceuticals and Nanologix

The main advantage of trading using opposite Madrigal Pharmaceuticals and Nanologix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Nanologix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanologix will offset losses from the drop in Nanologix's long position.
The idea behind Madrigal Pharmaceuticals and Nanologix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments